⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14059630 | 0.82 | — | — | |
| SCHEMBL14703573 | 0.72 | — | — | |
| SCHEMBL1930146 | 0.61 | — | — | |
| SCHEMBL12054244 | 0.61 | — | — | |
| SCHEMBL1276 | 0.61 | — | — | |
| Ammonia Solution, Strong SCHEMBL129411 | 0.55 | — | — | |
| SCHEMBL10519988 | 0.55 | — | — | |
| SCHEMBL12583446 | 0.55 | — | — | |
| SCHEMBL4636818 | 0.55 | — | — | |
| Phosphine SCHEMBL15477090 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262471-A1 | MULTIPLEX CANCER CELL PROFILING USING MS-TAGGED PROBES CONTAINING AN IMINOSYDNONE CLEAVABLE LINKER | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-12-26 | — | — | WO | claimed |
| EP-4667939-A1 | MULTIPLEX CANCER CELL PROFILING USING MS-TAGGED PROBES CONTAINING AN IMINOSYDNONE CLEAVABLE LINKER | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2025-12-24 | — | — | EP | claimed |
| US-20250057964-A1 | LIGAND-DRUG-CONJUGATE COMPRISING A SINGLE MOLECULAR WEIGHT POLYSARCOSINE | MABLINK BIOSCIENCE (FR) | 2025-02-20 | — | — | US | claimed |
| WO-2023040830-A1 | AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR | 北京华森英诺生物科技有限公司 | 2023-03-23 | — | — | WO | claimed |
| CN-114956934-A | Preparation method of intermediate for synthesizing novel deuterated cyano compound | 广州谷森制药有限公司 | 2022-08-30 | — | — | CN | claimed |
| EP-4739347-A1 | CONJUGATES OF DRUG UNITS AND TARGETING UNITS AND PRECURSOR COMPOUNDS THEREOF | Solve Therapeutics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4713020-A2 | DRUG-LINKERS AND DRUG CONJUGATES | Solve Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2025262471-A1 | MULTIPLEX CANCER CELL PROFILING USING MS-TAGGED PROBES CONTAINING AN IMINOSYDNONE CLEAVABLE LINKER | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-12-26 | — | — | WO | disclosed |
| EP-4667939-A1 | MULTIPLEX CANCER CELL PROFILING USING MS-TAGGED PROBES CONTAINING AN IMINOSYDNONE CLEAVABLE LINKER | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2025-12-24 | — | — | EP | disclosed |
| EP-3867248-B1 | PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS | NXERA PHARMA UK LTD (GB) | 2025-12-10 | — | — | EP | disclosed |
| US-20250115587-A1 | PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS | NXERA PHARMA UK LIMITED (GB) | 2025-04-10 | — | — | US | disclosed |
| US-12234227-B2 | Pyrazole derivatives as H4 antagonist compounds | NXERA PHARMA UK LIMITED (GB) | 2025-02-25 | — | — | US | disclosed |
| US-20100267721-A1 | Heterocyclic H3 Antagonists | HIGH POINT PHARMACEUTICALS LLC (US) | 2010-10-21 | — | — | US | disclosed |
| US-7642354-B2 | Use treating nervous system disorders, as neuroprotectants, gastrointestinal disorders, cardiovascular disorders; e.g. 2-(5-phenylpyridin-2-ylamino)-6-pyridin-2-ylpyrimidine | ICAGEN, INC. (US) | 2010-01-05 | — | — | US | disclosed |
| US-20090306197-A1 | Substituted Chromanol Derivatives and Their Use | BAYER HEALTHCARE AG (DE) | 2009-12-10 | — | — | US | disclosed |
| US-7560464-B2 | Polycyclic pyrimidines as potassium ion channel modulators | ICAGEN, INC. (US) | 2009-07-14 | — | — | US | disclosed |
| US-20080188481-A1 | INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC 4-ALKENYL PIPERIDINE AMIDES | BRISTOL-MYERS SQUIBB COMPANY | 2008-08-07 | — | — | US | disclosed |
| US-20080125439-A1 | DIAZAINDOLE-DICARBONYL-PIPERAZINYL ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2008-05-29 | — | — | US | disclosed |
| US-20080108600-A1 | Polycyclic Pyridines as Potassium Ion Channel Modulators | ICAGEN, INC. (US) | 2008-05-08 | — | — | US | disclosed |
| US-7348337-B2 | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-03-25 | — | — | US | disclosed |